ANDA 61888, held by Bristol. Tetracycline Hydrochloride.
As of Nov 16, 2026, ANDA 61888 (Bristacycline), held by Bristol, was first approved by FDA on Dec 5, 1974, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 5, 1974 | Original application | Approved | None posted |
| Bristacycline250MG · capsule;oral | Tetracycline Hydrochloride | Discontinued |
| Bristacycline500MG · capsule;oral | Tetracycline Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters